OraSure Technologies Inc/ US68554V1089 /
| 11/8/2024 10:00:00 PM | Chg. +0.0500 | Volume | Bid1:00:00 PM | Ask1:00:00 PM | High | Low |
|---|---|---|---|---|---|---|
| 4.2900USD | +1.18% | 534,677 Turnover: 1.8 mill. |
4.3000Bid Size: 1,000 | 4.7000Ask Size: 300 | 4.3550 | 4.1500 |
GlobeNewswire
7/22
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
GlobeNewswire
4/22
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
GlobeNewswire
2/13
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
GlobeNewswire
1/4
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Ge...
GlobeNewswire
12/19/2023
Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cance...
GlobeNewswire
11/7/2023
OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year
GlobeNewswire
10/23/2023
OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th
GlobeNewswire
9/11/2023
Aspira Women’s Health Announces Dr. Jody Berry as New Chief Scientific Officer
GlobeNewswire
3/29/2022
HOUSING WORKS & FOUNDING CHAIR JAMES HUNIFORD ANNOUNCE LINEUP OF TOP INTERIOR DESIGNERS FOR ANNUAL D...
GlobeNewswire
3/22/2022
OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensi...
GlobeNewswire
2/23/2022
OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up
GlobeNewswire
2/16/2022
OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022...
GlobeNewswire
1/31/2022
InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launch...
GlobeNewswire
1/13/2022
InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants
